Cera Sanitaryware Q4 Review - Healthy Margin Improvement Encouraging: IDBI Capital

BQ Prime’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BQ Prime’s subscribers an opportunity to expand their understanding of companies, sectors and the economy..IDBI Capital Report.Cera Sanitaryware Ltd.’s Q4 FY22 result was above our and consensus estimates on key parameters. Strong demand traction and consistent price hike taken aided healthy net sales growth and supported margin improvement. Net sales marginally declined by 6.5% YoY to Rs 4,099 million, while Ebitda came in at Rs 797 million, a healthy growth of 13.7% YoY. Cera Sanitaryware reported net profit of Rs 584 million, up by 22.4% over Q4 FY21. The company’s timely capacity expansion plan, focus on improving product mix, extensive distribution network, healthy balance sheet bodes well for sustainable earnings growth in future..Click on the attachment to read the full report:.DISCLAIMERThis report is authored by an external party. BQ Prime does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BQ Prime..Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

Cera Sanitaryware Q4 Review - Healthy Margin Improvement Encouraging: IDBI Capital

Cera Sanitaryware Q4 Review - Healthy Margin Improvement Encouraging: IDBI Capital

Choose a plan